Age at onset and gene variants predict lifespan and disease duration in childhood neuronal ceroid lipofuscinoses.
Alessandro Simonati, Francesco Pezzini, Nardo Nardocci and 1 others
PMID 40708162WHAT IT FOUND
In children with neuronal ceroid lipofuscinoses, the age at which symptoms first appear strongly predicts how long the patient lives.
Later onset meant significantly longer survival and disease duration, while early onset led to rapid decline. Genetic variant severity did not consistently predict this timeline.
Key findings
01The median age at death for the juvenile group was approximately double that of the late infantile group and four times that of the infantile group.
02A strong correlation between age at onset and age at death was observed in each age group, indicating that the timing of symptom onset is a primary determinant of disease duration and fatal outcome.
03High percentages of pathogenic variants were distributed across groups, and identifying pathogenic variants in the same gene did not always predict whether the clinical course would be severe or mild.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study is retrospective, relying on historical data that may lack uniformity in assessment methods. The sample size for the infantile group was small (13 patients), limiting the precision of estimates for this subgroup. The cohort was drawn from Italian centers, so results may not generalize to populations with different genetic backgrounds or healthcare systems. Many patients were censored, meaning their final age at death was not known, which relies on assumptions about disease duration.
Declared interests
The authors report no conflicts of interest. The study was funded by Italian government and research foundations, including the Ministry of Health and Fondazione Mariani.
The easy way to misread this
Do not assume that a specific genetic mutation alone determines how long a child will live. The study found that age at symptom onset was a stronger predictor of lifespan than the genetic variant's pathogenicity score, and identical mutations sometimes led to different clinical courses.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →